Cytochrome p 450 cyp2c19
Showing 1 - 25 of >10,000
Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant, Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant Trial in Bauru
Completed
- Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant
- Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant
-
Bauru, São Paulo, BrazilBauru School of Dentistry/USP
Nov 2, 2020
Cytochrome P450 Abnormalities in Patients With Delirium.
Completed
- Delirium, Cytochrome P-450 Enzyme System
- Cytochrome P450 test
-
Park Ridge, IllinoisDavid Ronin
Jul 14, 2020
Antipsychotic Induced Weight Gain, Non-alcoholic Steatohepatitis (NASH) Trial in Miami (Miricorilant, Fluvoxamine)
Recruiting
- Antipsychotic Induced Weight Gain
- Non-alcoholic Steatohepatitis (NASH)
-
Miami, FloridaSite 01
Feb 3, 2023
Parkinson Disease Trial in Madison (Tavapadon, Carbamazepine)
Active, not recruiting
- Parkinson Disease
-
Madison, WisconsinMadison, Wisconsin
Jan 13, 2023
Aspergillosis Invasive, Fungal Infection Trial in Toronto (Voriconazole genotype-specific dosing, Standard of Care)
Completed
- Aspergillosis Invasive
- Fungal Infection
- Voriconazole genotype-specific dosing
- Standard of Care
-
Toronto, Ontario, Canada
- +1 more
Nov 2, 2020
Atopic Dermatitis Trial (Caffeine, Metoprolol, Midazolam)
Not yet recruiting
- Atopic Dermatitis
- Caffeine
- +6 more
- (no location specified)
May 26, 2023
HIV Trial in Baltimore (VH4524184, Midazolam, Placebo)
Recruiting
- HIV Infections
- VH4524184
- +2 more
-
Baltimore, MarylandGSK Investigational Site
Jan 11, 2023
Drug Intolerance, Cytochrome P450 CYP2D6 Enzyme Deficiency, Drug Effect Trial in Geneva (Pupillometry)
Terminated
- Drug Intolerance
- +2 more
- Pupillometry
-
Geneva, SwitzerlandGeneva University Hospitals, Geneva, Switzerland
Nov 24, 2022
Atopic Dermatitis Trial in Bulgaria, United States (Nemolizumab, CYP 450 Substrates)
Recruiting
- Atopic Dermatitis
- Nemolizumab
- CYP 450 Substrates
-
North Hollywood, California
- +6 more
Nov 29, 2022
CYP2C19 Genetic Variants Trial in Stanford (Limonene)
Recruiting
- CYP2C19 Genetic Variants
- Limonene
-
Stanford, CaliforniaStanford School of Medicine
Aug 18, 2022
Based on CYP2C19 Genotype in Ischemic Stroke
Active, not recruiting
- Acute Ischemic Stroke
- General principles of care and judgement of researcher
-
Yongin-si, Gyeonggi-do, Korea, Republic of
- +36 more
Oct 23, 2022
Adverse Drug Events, Adverse Drug Reactions, Drug Interaction Potentiation Trial in Searcy (Pharmacogenetic testing)
Completed
- Adverse Drug Events
- +12 more
- Pharmacogenetic testing
-
Searcy, ArkansasWhite County Medical Center Home Health
Sep 18, 2019
Healthy Trial in Geneva (Dextromethorphan 5 MG, Paroxetine 10Mg Tablet, Paroxetine 20Mg Tablet)
Completed
- Healthy
- Dextromethorphan 5 MG
- +2 more
-
Geneva, SwitzerlandHUG
Jan 3, 2022
Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)
Not yet recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Vesatolimod
- +3 more
- (no location specified)
Jul 11, 2022
Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)
Not yet recruiting
- Atrial Fibrillation
- Coronary Artery Disease
- (no location specified)
Oct 22, 2023
Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)
Completed
- Ulcerative Colitis (UC)
- Crohn's Disease
- Risankizumab
- Cytochrome P450 (CYP) Substrates
-
Coronado, California
- +5 more
Oct 20, 2022
Drug-drug Interactions Trial in DeLand (napabucasin, cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate)
Completed
- Drug-drug Interactions
- napabucasin
- cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate
-
DeLand, FloridaAccel Research Sites
Apr 4, 2022
Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)
Not yet recruiting
- Coronary Artery Disease
- Platelet Reactivity
- CYP2C19 genotype guided P2Y12 monotherapy
- Clopidogrel
- (no location specified)
Mar 7, 2023
Rheumatoid Arthritis Trial in Wuhan (SHR0302 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)
Completed
- Rheumatoid Arthritis
- SHR0302 Tablets
- +5 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Dec 21, 2022
Drug Interaction Trial in Uppsala (Drug Drug Interaction)
Recruiting
- Drug Interaction
- Drug Drug Interaction
-
Uppsala, SwedenCTC Clinical Trial Consultants AB
Apr 13, 2023
Healthy Trial (Voriconazole 200mg, FluvoxaMINE 50 Mg Oral Tablet, Omeprazole 10 MG Oral Tablet)
Not yet recruiting
- Healthy
- Voriconazole 200mg
- +2 more
- (no location specified)
Feb 21, 2022